Skip to Content

Telavancin Injection

Last Updated: November 13, 2013
Status: Resolved

Products Affected - Description

Telavancin Injection

Reason for the Shortage

  • Theravance is the sole manufacturer of telavancin injection.
  • Theravance may re-introduce Vibativ 250 mg vials (NDC 52118-0002-01) in the future.

Available Products

Vibativ Injection, Theravance
750 mg vial, 10 count (NDC 52118-0001-01)

Estimated Resupply Dates

Theravance has Vibativ 750 mg vials available.

Related Shortages

Updated

November 13, 2013; September 16, 2013; August 15, 2013; August 12, 2013; July 3, 2013; June 11, 2013; April 29, 2013; March 15, 2013; January 11, 2013; November 13, 2012; September 4, 2012; June 4, 2012; April 10, 2012; February 24, 2012; January 20, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide